The Design and Rationale of the Trail1 Trial: A Randomized Double-Blind Phase 2 Clinical Trial of Pirfenidone in Rheumatoid Arthritis-Associated Interstitial Lung Disease
暂无分享,去创建一个
M. Kolb | I. Rosas | S. Hurwitz | D. Chambers | J. Solomon | S. Danoff | P. Dellaripa | F. Woodhead | H. Goldberg | Elizabeth Peters | D. DiFranco | Cathy Spino | Shana Haynes-Harp